Vu N. Ngo

17.1k total citations · 4 hit papers
42 papers, 7.6k citations indexed

About

Vu N. Ngo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Vu N. Ngo has authored 42 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Vu N. Ngo's work include T-cell and B-cell Immunology (13 papers), Immunotherapy and Immune Responses (12 papers) and Lymphoma Diagnosis and Treatment (9 papers). Vu N. Ngo is often cited by papers focused on T-cell and B-cell Immunology (13 papers), Immunotherapy and Immune Responses (12 papers) and Lymphoma Diagnosis and Treatment (9 papers). Vu N. Ngo collaborates with scholars based in United States, Germany and United Kingdom. Vu N. Ngo's co-authors include Jason G. Cyster, K. Mark Ansel, Eric H. Ekland, Paul Hyman, Jonathon D. Sedgwick, Michael D. Gunn, Louis M. Staudt, Martin Lipp, Reinhold Förster and Jeffrey L. Browning and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Vu N. Ngo

42 papers receiving 7.5k citations

Hit Papers

A chemokine-driven positive feedback loop organizes lymph... 1998 2026 2007 2016 2000 1998 2008 2001 250 500 750

Peers

Vu N. Ngo
Antonius Rolink Switzerland
Christine Ambrose United States
Larry Kane United States
Dennis Y. Loh United States
Anja Müller Germany
Teresa G. Cachero United States
Vu N. Ngo
Citations per year, relative to Vu N. Ngo Vu N. Ngo (= 1×) peers Robert Rottapel

Countries citing papers authored by Vu N. Ngo

Since Specialization
Citations

This map shows the geographic impact of Vu N. Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vu N. Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vu N. Ngo more than expected).

Fields of papers citing papers by Vu N. Ngo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vu N. Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vu N. Ngo. The network helps show where Vu N. Ngo may publish in the future.

Co-authorship network of co-authors of Vu N. Ngo

This figure shows the co-authorship network connecting the top 25 collaborators of Vu N. Ngo. A scholar is included among the top collaborators of Vu N. Ngo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vu N. Ngo. Vu N. Ngo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bates, Paul D., Peng Liu, Fen Zhu, et al.. (2024). Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma. Cell Reports Medicine. 5(4). 101484–101484. 5 indexed citations
2.
Chen, Robert, Alex F. Herrera, Lu Chen, et al.. (2019). Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma. Clinical Cancer Research. 26(5). 1034–1044. 61 indexed citations
3.
Zhang, Xu Hannah, Vu N. Ngo, Qi Cui, et al.. (2016). Role of p38γ - NFATc4 - IL17A Pathway As a Potential Therapeutic Target in Cutaneous T Cell Lymphoma. Blood. 128(22). 2725–2725. 1 indexed citations
4.
Yeung, Choh, Vu N. Ngo, Patrick J. Grohar, et al.. (2013). Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene. 32(47). 5429–5438. 36 indexed citations
5.
Lamy, Laurence, Vu N. Ngo, N. C. Tolga Emre, et al.. (2013). Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma. Cancer Cell. 23(4). 435–449. 185 indexed citations
6.
Wang, Yihua, Vu N. Ngo, Martyna Marani, et al.. (2010). Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells. Oncogene. 29(33). 4658–4670. 95 indexed citations
7.
Hailfinger, Stephan, Georg Lenz, Vu N. Ngo, et al.. (2009). Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences. 106(47). 19946–19951. 170 indexed citations
8.
Shaffer, Arthur L., N. C. Tolga Emre, Laurence Lamy, et al.. (2008). IRF4 addiction in multiple myeloma. Nature. 454(7201). 226–231. 507 indexed citations breakdown →
9.
Bidère, Nicolas, Vu N. Ngo, Cailin Collins, et al.. (2008). Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival. Nature. 458(7234). 92–96. 123 indexed citations
10.
Ngo, Vu N., R. Eric Davis, Laurence Lamy, et al.. (2006). A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 441(7089). 106–110. 455 indexed citations
11.
Shaffer, Arthur L., George W. Wright, Liming Yang, et al.. (2006). A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunological Reviews. 210(1). 67–85. 141 indexed citations
12.
Cupedo, Tom, Frances E. Lund, Vu N. Ngo, et al.. (2004). Initiation of Cellular Organization in Lymph Nodes Is Regulated by Non-B Cell-Derived Signals and Is Not Dependent on CXC Chemokine Ligand 13. The Journal of Immunology. 173(8). 4889–4896. 66 indexed citations
13.
Okada, Takaharu, Vu N. Ngo, Eric H. Ekland, et al.. (2002). Chemokine Requirements for B Cell Entry to Lymph Nodes and Peyer's Patches. The Journal of Experimental Medicine. 196(1). 65–75. 388 indexed citations
14.
Cyster, Jason G., K. Mark Ansel, Vu N. Ngo, Diana C. Hargreaves, & Theresa T. Lu. (2002). Traffic Patterns of B Cells and Plasma Cells. Advances in experimental medicine and biology. 512. 35–41. 15 indexed citations
15.
Ngo, Vu N., Richard J. Cornall, & Jason G. Cyster. (2001). Splenic T Zone Development Is B Cell Dependent. The Journal of Experimental Medicine. 194(11). 1649–1660. 205 indexed citations
16.
Hargreaves, Diana C., Paul Hyman, Theresa T. Lu, et al.. (2001). A Coordinated Change in Chemokine Responsiveness Guides Plasma Cell Movements. The Journal of Experimental Medicine. 194(1). 45–56. 506 indexed citations breakdown →
17.
Ansel, K. Mark, Vu N. Ngo, Paul Hyman, et al.. (2000). A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 406(6793). 309–314. 976 indexed citations breakdown →
18.
Cyster, Jason G., Vu N. Ngo, Eric H. Ekland, et al.. (1999). Chemokines and B-cell Homing to Follicles. Current topics in microbiology and immunology. 246. 87–93. 62 indexed citations
19.
Gunn, Michael D., Vu N. Ngo, K. Mark Ansel, et al.. (1998). A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 391(6669). 799–803. 674 indexed citations breakdown →
20.
Woronicz, John, Barbara J. Calnan, Vu N. Ngo, & Astar Winoto. (1994). Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature. 367(6460). 277–281. 490 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026